J.L. Coenen

Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma

Sonja Zweegman, Bronno van der Holt, Ulf‐Henrik Mellqvist et al. · Blood · 2016 · 112 citations · Full text

Medicine, Hematology, Oncology +14

Measurements of serum ferritin used to predict concentrations of iron in bone marrow in anemia of chronic disease

J.L. Coenen, M.P. van Dieijen-Visser, Jos van Pelt et al. · Clinical Chemistry · 1991 · 80 citations

Medicine, Hematology, Pathology +17

Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial

Nick de Jonge, Jonne J. Sikkens, Sonja Zweegman et al. · The Lancet Haematology · 2022 · 47 citations · Full text

Pharmacy, Clinical Sciences, Infectious Diseases +16

Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)

Hielke J. Meulenbeld, Erik van Werkhoven, J.L. Coenen et al. · European Journal of Cancer · 2012 · 35 citations

Medicine, Oncology, Urology +14

Health-related quality of life in transplant ineligible newly diagnosed multiple myeloma patients treated with either thalidomide or lenalidomide-based regimen until progression: a prospective, open-label, multicenter, randomized, phase 3 study

Lene Kongsgaard Nielsen, Claudia A.M. Stege, Birgit I. Lissenberg‐Witte et al. · Haematologica · 2019 · 32 citations · Full text

Medicine, Oncology, Pharmacotherapy +17